NeuroOne Medical Technologies Corporation reported earnings results for the first quarter ended December 31, 2022. For the first quarter, the company reported net loss was USD 1.73 million compared to USD 2.81 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.18 a year ago.
NeuroOne Medical Technologies Corporation
Equities
NMTC
US64130M2098
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9517 USD | +2.34% | -10.22% | -39.77% |
05-31 | NeuroOne Medical Files Shelf Registration For $150 Million Securities Offering | MT |
05-14 | Transcript : NeuroOne Medical Technologies Corporation, Q2 2024 Earnings Call, May 14, 2024 |
1st Jan change | Capi. | |
---|---|---|
-39.77% | 25.89M | |
-28.18% | 16.33B | |
-39.00% | 2.96B | |
+20.05% | 1.82B | |
-9.59% | 1.55B | |
+39.04% | 1.41B | |
-18.07% | 976M | |
-27.78% | 846M | |
+4.12% | 811M | |
-22.44% | 631M |
- Stock Market
- Equities
- NMTC Stock
- News NeuroOne Medical Technologies Corporation
- NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2022